Procyon completes the acquisition of Bioxalis Medica Inc. and closes a concurrent financing of $ 3.5 M.

PR Newswire | June 30, 2005 | Copyright

The Company expands its oncology portfolio with an innovative technology platform for cancer therapy

MONTREAL, QC, June 30 /PRNewswire-FirstCall/ -- Procyon Biopharma Inc. (TSX: PBP) today announced the successful acquisition of Bioxalis Medica Inc. (Bioxalis), a Montreal-based biopharmaceutical company committed to the discovery and development of targeted liposomes for cancer treatment and the completion of a concurrent non-brokered $3,500,000 financing of new cash by way of a private placement in debentures.

The acquisition

The acquisition of ...

Read all of this article with a FREE trial to HighBeam Research

Related newspaper, magazine, and trade journal articles from HighBeam Research

(Including press releases, facts, information, and biographies)

Montalembert, Charles de. Journal intime inedit, volume VI (1854-1858).(Book review)
Magazine article from: Nineteenth-Century French Studies ; Montalembert, Charles de. Journal intime...7453-1358-4 Charles-Forbes-Rene, Comte de Montalembert, Catholic publicist...and his mother, nee Forbes, was from an old...Granard belonged. Charles went on to study philosophy...

Find more facts and information related to the article "Procyon completes the acquisition of Bioxalis ..."